Novo Nordisk overtakes giants in market value
Novo Nordisk has overtaken several international giants in 2022 measured on market value.
The Danish pharmaceutical company’s equity appreciated by 27% this year and closed at record prices several times. Thus, the company is advancing on the list of the world’s largest listed companies. Novo Nordisk is currently number 27 with a company valuation of almost USD 300bn, according to the list published shortly before Christmas.
Pfizer is just at Novo Nordisk’s heals with a USD 290bn market value. Novo Nordisk is above big names like Coca-Cola, Disney, Bank of America, Nike and Alibaba.
Despite new diabetes treatments, Novo Nordisk predicts long-term success for insulin
Novo Nordisk ends 2022 triumphantly – and next year is looking even better
Novo Nordisk buys access to try out long-acting injection technology
